Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 8.


Bateman, RM, Sharpe, MD, Jagger, JE, Ellis, CG, Solé-Violán, J, López-Rodríguez, M, Herrera-Ramos, E, Ruíz-Hernández, J, Borderías, L, Horcajada, J
et al (show 2431 more authors) (2016) 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. Critical care (London, England), 20 (Suppl ). 94-.


Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Ghaneh, P, Psarelli, EE ORCID: 0000-0002-3102-0288, Valle, JW, Halloran, CM ORCID: 0000-0002-5471-4178, Faluyi, O, O'Reilly, DA, Cunningham, D, Wadsley, J
et al (show 24 more authors) (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet (London, England), 389 (10073). pp. 1011-1024.


Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Ghaneh, P, Psarelli, EE ORCID: 0000-0002-3102-0288, Valle, JW, Halloran, CM ORCID: 0000-0002-5471-4178, Faluyi, O, O'Reilly, DA, Cunningham, D, Wadsley, J
et al (show 24 more authors) (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet (London, England), 389 (10073). 1011 - 1024.


Edeline, J, Blanc, J-F, Campillo-Gimenez, B, Ma, Y-T, King, J, Faluyi, O, Mathurin, J, Ghazi, S, Palmer, DH ORCID: 0000-0002-7147-5703 and Meyer, T
(2017) Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic score. European Journal of Cancer, 86. pp. 135-142.


King, J, Palmer, DH ORCID: 0000-0002-7147-5703, Johnson, P ORCID: 0000-0003-1404-0209, Ross, P, Hubner, RA, Sumpter, K, Darby, S, Braconi, C, Iwuji, C, Swinson, D
et al (show 8 more authors) (2017) Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK Audit. Clinical oncology (Royal College of Radiologists (Great Britain)), 29 (4). pp. 256-262.


Edeline, J, Blanc, J-F, Johnson, P ORCID: 0000-0003-1404-0209, Campillo-Gimenez, B, Ross, P, Ma, YT, King, J, Hubner, RA, Sumpter, K, Darby, S
et al (show 8 more authors) (2016) A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma. Liver international : official journal of the International Association for the Study of the Liver, 36 (12). pp. 1821-1828.


Palmer, DH ORCID: 0000-0002-7147-5703, Ma, YT, Peck-Radosavljevic, M, Ross, P, Graham, J, Fartoux, L, Deptala, A, Studeny, M, Schnell, D, Hocke, J
et al (show 2 more authors) (2018) A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinoma. British Journal of Cancer, 118 (9). pp. 1162-1168.


Kadalayil, L ORCID: 0000-0002-3757-5487, Benini, R, Pallan, L, O'Beirne, J ORCID: 0000-0003-3400-2816, Marelli, L, Yu, D, Hackshaw, A, Fox, R, Johnson, P ORCID: 0000-0003-1404-0209, Burroughs, AK
et al (show 2 more authors) (2013) A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 24 (10). pp. 2565-2570.

This list was generated on Sun Mar 10 22:04:22 2024 GMT.